A strategy of novel molecular hydrogen-producing antioxidative auxiliary system improves virus production in cell bioreactor

Sci Rep. 2024 Feb 19;14(1):4092. doi: 10.1038/s41598-024-54847-7.

Abstract

In the increasing demand for virus vaccines, large-scale production of safe, efficient, and economical viral antigens has become a significant challenge. High-cell-density manufacturing processes are the most commonly used to produce vaccine antigens and protein drugs. However, the cellular stress response in large-scale cell culture may directly affect host cell growth and metabolism, reducing antigen production and increasing production costs. This study provided a novel strategy of the antioxidant auxiliary system (AAS) to supply molecular hydrogen (H2) into the cell culture media via proton exchange membrane (PEM) electrolysis. Integrated with a high-density cell bioreactor, the AAS aims to alleviate cellular stress response and increase viral vaccine production. In the results, the AAS stably maintained H2 concentration in media even in the high-air exposure tiding cell bioreactor. H2 treatment was shown safe to cell culture and effectively alleviated oxidative stress. In two established virus cultures models, bovine epidemic fever virus (BEFV) and porcine circovirus virus type 2 (PCV-2), were employed to verify the efficacy of AAS. The virus yield was increased by 3.7 and 2.5 folds in BEFV and PCV-2 respectively. In conclusion, the AAS-connected bioreactor effectively alleviated cellular oxidative stress and enhanced virus production in high-density cell culture.

Keywords: Antioxidative auxiliary system (AAS); Cellular stress response; High-density cell bioreactor; Hydrogen molecules (H2); Vaccine; Viral production.

MeSH terms

  • Animals
  • Antioxidants*
  • Bioreactors
  • Cattle
  • Cell Culture Techniques / methods
  • Hydrogen
  • Swine
  • Viral Vaccines*

Substances

  • Antioxidants
  • Viral Vaccines
  • Hydrogen